2441 – 2450 of 3787
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Changes in body composition as assessed by DXA scan after one year of high dose growth hormone treatment in children born SGA. Results from the NESGAS group
(
- Contribution to journal › Published meeting abstract
-
Mark
Beneficial effects of growth hormone treatment in boys with Aarskog syndrome
(
- Contribution to journal › Published meeting abstract
-
Mark
Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial
(
- Contribution to journal › Article
-
Mark
Common variants at 30 loci contribute to polygenic dyslipidemia
(
- Contribution to journal › Article
-
Mark
Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control
(
- Contribution to journal › Article
-
Mark
Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005-a register-based approach
(
- Contribution to journal › Article
-
Mark
Phenotypic characteristics of short children born SGA. Baseline data from the North European small for gestational age study (NESGAS)
(
- Contribution to journal › Published meeting abstract
-
Mark
Differential Islet and Incretin Hormone Responses in Morning vs. Afternoon after Standardized Meal in Healthy Men.
(
- Contribution to journal › Article
-
Mark
Perilipin is present in islets of Langerhans and protects against lipotoxicity when overexpressed in the beta-cell line INS-1.
(
- Contribution to journal › Article
-
Mark
Hyperactivity in adrenergic signalling via alpha2A receptors contributes to human type 2 diabetes
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.108-108(
- Contribution to journal › Published meeting abstract